Form 8-K - Current report:
SEC Accession No. 0001829126-25-004053
Filing Date
2025-05-29
Accepted
2025-05-29 17:20:29
Documents
15
Period of Report
2024-10-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K opgeninc_8k.htm   iXBRL 8-K 35304
2 EXHIBIT 10.1 opgeninc_ex10-1.htm EX-10.1 56400
3 EXHIBIT 10.2 opgeninc_ex10-2.htm EX-10.2 44436
4 EXHIBIT 10.3 opgeninc_ex10-3.htm EX-10.3 114377
  Complete submission text file 0001829126-25-004053.txt   447006

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE opgn-20241002.xsd EX-101.SCH 2990
6 XBRL LABEL FILE opgn-20241002_lab.xml EX-101.LAB 34239
7 XBRL PRESENTATION FILE opgn-20241002_pre.xml EX-101.PRE 22342
17 EXTRACTED XBRL INSTANCE DOCUMENT opgeninc_8k_htm.xml XML 3651
Mailing Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850
Business Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 301-869-9683
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

EIN.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37367 | Film No.: 251004826
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)